These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11374045)

  • 1. Prognostic importance of isolated peritumoral lymphangiosis carcinomatosa in lymph-node-negative colorectal carcinoma.
    Meyer W; Awad-Allah A; Steinhäuser BB; Jurowich C; Kaiser A; Gebhardt C
    Langenbecks Arch Surg; 2001 Mar; 386(2):124-31. PubMed ID: 11374045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors of lymph node-negative metastasis gastric cancer].
    Sun D; Xu H; Huang J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer.
    Rosenberg R; Friederichs J; Gertler R; Hoos A; Mueller J; Nahrig J; Nekarda H; Siewert JR
    Int J Colorectal Dis; 2004 Sep; 19(5):430-7. PubMed ID: 14716495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients.
    Rosenberg R; Hoos A; Mueller J; Baier P; Stricker D; Werner M; Nekarda H; Siewert JR
    J Clin Oncol; 2002 Feb; 20(4):1049-55. PubMed ID: 11844829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years.
    Akagi Y; Adachi Y; Ohchi T; Kinugasa T; Shirouzu K
    Anticancer Res; 2013 Jul; 33(7):2965-70. PubMed ID: 23780987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lymph node evaluation in colorectal cancer].
    Pereira T; Torres RA; Nogueira AM
    Arq Gastroenterol; 2006; 43(2):89-93. PubMed ID: 17119661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma.
    Choi HJ; Choi YY; Hong SH
    Dis Colon Rectum; 2002 Jun; 45(6):750-5; discussion755-6. PubMed ID: 12072625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated tumor cells in regional lymph nodes as relapse predictors in stage I and II colorectal cancer.
    Mescoli C; Albertoni L; Pucciarelli S; Giacomelli L; Russo VM; Fassan M; Nitti D; Rugge M
    J Clin Oncol; 2012 Mar; 30(9):965-71. PubMed ID: 22355061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
    Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
    J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor invasion of lymph node capsules in patients with Dukes C colorectal adenocarcinoma.
    Yano H; Saito Y; Kirihara Y; Takashima J
    Dis Colon Rectum; 2006 Dec; 49(12):1867-77. PubMed ID: 17080279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic relevance of occult tumor cells in lymph nodes of colorectal carcinomas: an immunohistochemical study.
    Broll R; Schauer V; Schimmelpenning H; Strik M; Woltmann A; Best R; Bruch HP; Duchrow M
    Dis Colon Rectum; 1997 Dec; 40(12):1465-71. PubMed ID: 9407986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients with recurrent breast cancer: does the primary axillary lymph node status predict more aggressive tumor progression?
    Rack B; Janni W; Gerber B; Strobl B; Schindlbeck C; Klanner E; Rammel G; Sommer H; Dimpfl T; Friese K
    Breast Cancer Res Treat; 2003 Nov; 82(2):83-92. PubMed ID: 14692652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors in the operative treatment of ductal pancreatic carcinoma.
    Gebhardt C; Meyer W; Reichel M; Wünsch PH
    Langenbecks Arch Surg; 2000 Jan; 385(1):14-20. PubMed ID: 10664114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of classified extramural tumor deposits and extracapsular lymph node invasion in T3-4 colorectal cancer: a retrospective single-center study.
    Yamano T; Semba S; Noda M; Yoshimura M; Kobayashi M; Hamanaka M; Beppu N; Yano A; Tsukamoto K; Matsubara N; Tomita N
    BMC Cancer; 2015 Nov; 15():859. PubMed ID: 26545360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor budding as an indicator of isolated tumor cells in lymph nodes from patients with node-negative colorectal cancer.
    Park SY; Choe G; Lee HS; Jung SY; Park JG; Kim WH
    Dis Colon Rectum; 2005 Feb; 48(2):292-302. PubMed ID: 15616755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphovascular invasion as a predictor for lymph node metastasis and a prognostic factor in gastric cancer patients under 70 years of age: A retrospective analysis.
    Zhang CD; Ning FL; Zeng XT; Dai DQ
    Int J Surg; 2018 May; 53():214-220. PubMed ID: 29609047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.
    Ahmed S; Leis A; Chandra-Kanthan S; Fields A; Zaidi A; Abbas T; Le D; Reeder B; Pahwa P
    Ann Surg Oncol; 2016 Jul; 23(7):2287-94. PubMed ID: 27016291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytic lymph node number establishes staging accuracy by occult tumor burden in colorectal cancer.
    Hyslop T; Weinberg DS; Schulz S; Barkun A; Waldman SA
    J Surg Oncol; 2012 Jul; 106(1):24-30. PubMed ID: 22252429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China.
    Sun ZQ; Ma S; Zhou QB; Yang SX; Chang Y; Zeng XY; Ren WG; Han FH; Xie X; Zeng FY; Sun XT; Wang GX; Li Z; Zhang ZY; Song JM; Liu JB; Yuan WT
    World J Gastroenterol; 2017 Dec; 23(48):8582-8590. PubMed ID: 29358866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.